📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
DCM Shriram to Raise USD 90 Million from IFC via Sustainability-Linked NCDs
DCM Shriram Limited has secured a USD 90 million investment commitment from the International Finance Corporation (IFC) through Sustainability-Linked Non-Convertible Debentures (NCDs). The capital is earmarked for the expansion of the company's downstream chemicals business and capital expenditures in its agri-business segment. This transaction is structured under a newly developed Sustainability-Linked Loan framework, independently assured by CareEdge ESG. The partnership aims to enhance industrial capabilities and support rural job creation while aligning with global ESG standards.
Key Highlights
Secured USD 90 million investment commitment from IFC, the private sector arm of the World Bank Group
Funds to be raised through Sustainability-Linked Non-Convertible Debentures (NCDs)
Proceeds allocated for downstream chemicals expansion and agri-business growth initiatives
Framework independently reviewed and assured by CareEdge ESG to ensure transparency
Strategic focus on strengthening the manufacturing base and rural supply chains in India
💼 Action for Investors
This is a positive signal as it secures long-term growth capital from a reputable global institution at likely competitive terms. Investors should monitor the timely execution of the chemicals expansion project, which is expected to be a key value driver.
DCM Shriram to Invest Rs 217 Cr for 48 MW Renewable Energy Project at Bharuch Plant
DCM Shriram's board has approved a total investment of Rs 217 crores to significantly enhance renewable energy capacity at its Bharuch facility. The plan involves an equity investment of up to Rs 87 crores for a minimum 26% stake in Special Purpose Vehicles and a capital expenditure of Rs 130 crores for infrastructure. This project will add 48 MW of renewable power, nearly doubling the plant's current RE provision from 50.4 MW to 98.4 MW. The project is expected to be completed by June 2027, aiming for 30 MW of round-the-clock power supply.
Key Highlights
Approved equity investment of up to Rs 87 crores for minimum 26% stake in RE SPVs
Sanctioned Rs 130 crores for infrastructure development related to the power project
Total renewable power capacity at Bharuch plant to increase from 50.4 MW to 98.4 MW
Project aims to provide 30 MW round-the-clock power at 75% Capacity Utilization Factor
Indicative timeline for project completion is set for June 2027
💼 Action for Investors
Investors should monitor the progress of this green energy transition as it is likely to reduce long-term power costs and improve ESG ratings. The substantial increase in RE capacity at the Bharuch plant suggests a focus on operational efficiency and sustainability.
DCM Shriram Q3 FY26 Revenue Up 13% to ₹3,811 Cr; Announces 180% Interim Dividend
DCM Shriram reported a 13% YoY increase in Q3 FY26 revenue to ₹3,811 crore, driven by strong performance in Chemicals and Sugar segments. PBDIT grew 4% to ₹560 crore, while PAT was impacted by a ₹55 crore exceptional item related to the implementation of new labor codes. The Chemicals segment saw 30% revenue growth despite lower ECU prices, and the Sugar segment benefited from higher volumes and a ₹36 crore provision reversal. The board declared an interim dividend of 180%, reflecting steady cash flow despite ongoing capital expenditure.
Key Highlights
Q3 FY26 Revenue rose 13% YoY to ₹3,811 crore, while PBDIT increased 4% to ₹560 crore.
Chemicals revenue jumped 30% YoY, supported by new projects like Hydrogen Peroxide and Epoxy, despite a 4% drop in ECUs.
Sugar & Ethanol PBDIT surged to ₹204 crore from ₹112 crore last year, aided by a ₹36 crore provision reversal.
Net debt stood at ₹1,084 crore as of Dec 31, 2025, down from ₹1,395 crore in March 2025.
Board declared an interim dividend of 180% amounting to a total payout of ₹56.14 crore.
💼 Action for Investors
Investors should monitor the stabilization of the newly commissioned Epichlorohydrin (ECH) plant and the upcoming aluminum extrusion project at Kota. The company's diversified portfolio and consistent dividend payouts make it a resilient pick in the industrial and agri-input space.
DCM Shriram Q3 FY26: Revenue Up 13% to ₹3,811 Cr; PAT Dips 19% on Exceptional Charge
DCM Shriram reported a resilient Q3 FY26 with consolidated net revenue rising 13% YoY to ₹3,811 crore, driven by a 30% growth in the Chemicals segment and a 28% jump in Fenesta. While PBDIT grew 4% to ₹560 crore, PAT declined 19% YoY to ₹213 crore due to a one-time exceptional charge of ₹55 crore related to new labor codes. The company is successfully diversifying into downstream chemicals like Epichlorohydrin and Epoxy resins, which are seeing good market traction. A dividend of ₹56.14 crores was also announced during the quarter.
Key Highlights
Consolidated Net Revenue grew 13% YoY to ₹3,811 crore, supported by volume-led growth in Chemicals.
PAT decreased by 19% YoY to ₹213 crore, impacted by a ₹55 crore one-time labor code provision.
Chemicals revenue surged 30% YoY following the commissioning of new projects and the Epoxy plant acquisition.
Shriram Farm Solutions achieved its highest-ever quarterly sales in research wheat seed, contributing to 7% segment growth.
Fenesta Building Systems continued its strong momentum with a 28% YoY revenue increase.
💼 Action for Investors
Investors should focus on the successful ramp-up of new chemical capacities and the potential margin improvement from anti-dumping duties on Epoxy resins. The company's diversified model provides stability, though sugar sector cost pressures remain a point to watch.
DCM Shriram Q3 FY26 Revenue Rises 13% to ₹3,811 Cr; Announces 180% Interim Dividend
DCM Shriram reported a 13% YoY growth in Q3 FY26 revenue at ₹3,811 crore, driven by strong performance in the Chemicals and Sugar segments. While PBDIT grew 4% to ₹560 crore, PAT declined 19% to ₹213 crore primarily due to a ₹55 crore exceptional item related to new labor codes. The company is aggressively expanding its chemicals portfolio with the commissioning of the Epichlorohydrin (ECH) plant and the acquisition of HSCL for epoxy resins. The board has declared an interim dividend of 180%, bringing the total dividend for the year to 360%.
Key Highlights
Consolidated Revenue for Q3 FY26 grew 13% YoY to ₹3,811 crore, while 9M FY26 PBDIT rose 24% to ₹1,294 crore.
Chemicals segment revenue surged 30% YoY in Q3, supported by a 6% increase in Caustic volumes and new project contributions.
Sugar & Ethanol segment revenue increased 15% YoY in Q3, aided by higher domestic sugar prices and a ₹36 crore reversal of ethanol duty provisions.
Fenesta Building Systems saw a 28% revenue jump in Q3, although margins were pressured by product mix and expansion costs.
Net Debt increased to ₹1,084 crore from ₹867 crore last year to fund ongoing capital expenditure and strategic acquisitions.
💼 Action for Investors
Investors should monitor the ramp-up of new chemical adjacencies like ECH and Epoxy, which are expected to enhance integrated utilization and drive future margins. The company remains a strong play on industrial chemicals and agri-business integration with a consistent dividend track record.
DCM Shriram Q3 PAT Falls 19% to Rs 201 Cr; Declares Rs 3.60 Interim Dividend
DCM Shriram reported a 12.6% YoY increase in standalone revenue to Rs 3,858 crore for Q3 FY26, while Profit After Tax (PAT) declined 19% to Rs 201 crore. The earnings were significantly impacted by a one-time exceptional provision of Rs 55 crore for the new statutory Labour Codes. The Board declared a second interim dividend of Rs 3.60 per share, with the record date set for January 24, 2026. For the nine-month period, the company maintains a healthy growth with PAT at Rs 466.56 crore versus Rs 391.84 crore last year.
Key Highlights
Standalone Revenue from operations rose 12.6% YoY to Rs 3,858.02 crore in Q3 FY26.
Net Profit (PAT) decreased 19.1% YoY to Rs 201.36 crore due to a Rs 55 crore exceptional charge.
Declared a second interim dividend of Rs 3.60 per share (180% of face value).
EBIDTA grew 4.5% YoY to Rs 540.03 crore, reflecting stable operational performance.
The record date for the interim dividend is fixed as January 24, 2026.
💼 Action for Investors
The stock remains a steady dividend payer, but the exceptional hit to margins this quarter suggests a neutral outlook. Long-term investors should watch for recovery in seasonal segments and clarity on labour code liabilities.
DCM Shriram Q3 FY26: Revenue Up 12.7% to ₹3,858 Cr; Declares ₹3.60 Interim Dividend
DCM Shriram reported a 12.7% YoY increase in standalone revenue to ₹3,858.02 crore for the quarter ended December 31, 2025. Standalone Profit After Tax (PAT) declined by 19.1% YoY to ₹201.36 crore, largely due to a one-time exceptional provision of ₹55 crore for the new Labour Codes. The company declared a second interim dividend of ₹3.60 per share, bringing the total interim dividend for FY26 to ₹7.20. Despite the PAT drop, operational EBITDA grew 4.5% YoY to ₹540.03 crore, indicating stable core performance.
Key Highlights
Standalone Revenue from operations grew 12.7% YoY to ₹3,858.02 crore from ₹3,424.59 crore.
Standalone PAT fell 19.1% YoY to ₹201.36 crore, impacted by a ₹55 crore exceptional item for Labour Code compliance.
Declared 2nd interim dividend of ₹3.60 per share (180%) with a record date of January 24, 2026.
EBITDA (before exceptional items) increased by 4.5% YoY to ₹540.03 crore.
9M FY26 Standalone PAT stands at ₹466.56 crore, up 19% compared to ₹391.84 crore in 9M FY25.
💼 Action for Investors
Investors should view the PAT decline as a one-time regulatory adjustment rather than an operational failure, as EBITDA and revenue show growth. The consistent dividend payout remains a positive for long-term shareholders.
DCM Shriram Board to Meet Jan 20 for Q3 Results and 2nd Interim Dividend
DCM Shriram Limited has scheduled a board meeting on January 20, 2026, to approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The board will also consider the declaration of a second interim dividend for the financial year 2025-26. If approved, the company has already fixed January 24, 2026, as the record date for determining shareholder eligibility. The trading window for the company's equity shares is currently closed and will remain so until January 22, 2026.
Key Highlights
Board meeting scheduled for January 20, 2026, to discuss Q3 results and dividend.
Record date for the potential 2nd interim dividend is set for January 24, 2026.
Trading window remains closed from January 1 to January 22, 2026.
The meeting will cover both standalone and consolidated financial results for the nine-month period.
💼 Action for Investors
Investors should watch for the dividend amount and Q3 earnings performance on January 20. To be eligible for the dividend, ensure shares are held in the demat account by the record date of January 24.
DCM Shriram and Bayer Crop Science Sign Strategic MoU for Sustainable Agriculture
DCM Shriram Limited has signed a Memorandum of Understanding (MoU) with Bayer Crop Science Limited to jointly explore opportunities in India's agriculture ecosystem. The partnership focuses on agri-inputs, digital advisory, seeds, and specialty plant nutrition, leveraging Bayer's global R&D and DCM Shriram's extensive rural footprint. The collaboration also extends to exploring synergies in the chemicals business and sustainable initiatives like carbon sequestration. This strategic alliance aims to enhance farmer productivity and create long-term value through integrated crop management solutions.
Key Highlights
Strategic MoU signed on December 10, 2025, to advance sustainable and future-ready agriculture.
Collaboration covers agri-inputs, digital tools, seeds, specialty plant nutrition, and biologicals.
Companies to evaluate joint opportunities in select areas of the chemicals business.
Focus on soil health, carbon sequestration, and integrated crop management pilots.
Combines Bayer's global expertise with DCM Shriram's deep rural engagement and manufacturing capabilities.
💼 Action for Investors
This partnership with a global leader like Bayer is a significant positive for DCM Shriram's agri-business segment. Investors should monitor for specific product launches or revenue-generating projects resulting from this collaboration over the next few quarters.